Cargando…
Loss of tumor suppressor WWOX accelerates pancreatic cancer development through promotion of TGFβ/BMP2 signaling
Pancreatic cancer is one of the most lethal cancers, owing to its late diagnosis and resistance to chemotherapy. The tumor suppressor WW domain-containing oxidoreductase (WWOX), one of the most active fragile sites in the human genome (FRA16D), is commonly altered in pancreatic cancer. However, the...
Autores principales: | Husanie, Hussam, Abu-Remaileh, Muhannad, Maroun, Kian, Abu-Tair, Lina, Safadi, Hazem, Atlan, Karine, Golan, Talia, Aqeilan, Rami I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792466/ https://www.ncbi.nlm.nih.gov/pubmed/36572673 http://dx.doi.org/10.1038/s41419-022-05519-9 |
Ejemplares similares
-
WWOX loss activates aerobic glycolysis
por: Abu-Remaileh, Muhannad, et al.
Publicado: (2014) -
WWOX controls hepatic HIF1α to suppress hepatocyte proliferation and neoplasia
por: Abu-Remaileh, Muhannad, et al.
Publicado: (2018) -
Author Correction: WWOX controls hepatic HIF1α to suppress hepatocyte proliferation and neoplasia
por: Abu-Remaileh, Muhannad, et al.
Publicado: (2018) -
WWOX somatic ablation in skeletal muscles alters glucose metabolism
por: Abu-Remaileh, Muhannad, et al.
Publicado: (2019) -
Neonatal neuronal WWOX gene therapy rescues Wwox null phenotypes
por: Repudi, Srinivasarao, et al.
Publicado: (2021)